Sign Up Now For
Our FREE E-mail Newsletter

In each issue of HEALTHbeat:

  • Get trusted advice from the doctors at Harvard Medical School
  • Learn tips for living a healthy lifestyle
  • Stay up-to-date on the latest developments in health
  • Receive special offers on health books and reports
  • Plus, receive your FREE Bonus Report, Living to 100: What's the secret?

[ Maybe Later ] [ No Thanks ]

Check out these newly released Special Health Reports from Harvard Medical School
Learn How

New Releases

You can't buy good health but you can buy good health information. Check out these newly released Special Health Reports from Harvard Medical School:

Risks and benefits of proton-pump inhibitors for excess stomach acid, from the Harvard Health Letter

Stomach acid is a valuable contributor to digestion, but too much can lead to heartburn and sometimes ulcers. Several types of medications are used to treat excess acid. One group commonly used for this are the proton-pump inhibitors (PPIs), such as Prevacid (lansoprazole), Prilosec (omeprazole), and Nexium (esomeprazole). These are generally considered to be safe and effective. But according to the April 2011 issue of the Harvard Health Letter, there are some new doubts about the safety of PPIs, including the following concerns:

Interaction with clopidogrel. Clopidogrel (Plavix) is a drug that discourages the formation of artery-clogging blood clots. But clopidogrel is hard on the lining of the stomach and intestines, so many doctors prescribe a PPI to be taken along with it. Two years ago, the FDA issued a strong warning that said some PPIs may cut clopidogrel’s effectiveness in half. However, two recent studies showed that those taking a PPI with clopidogrel had no increase in heart attack or stroke and did have substantially less risk for gastrointestinal bleeds.

Fracture risk. Some research shows that suppression of stomach acid could reduce the body’s ability to absorb calcium, which could lead to osteoporosis, weaker bones, and a greater chance of breaking a bone. The risk is probably pretty small, but it’s another reason to take PPIs only when necessary.

Pneumonia risk. Several studies have shown that people who take a PPI are more likely to catch pneumonia than those who don't take one.

The Harvard Health Letter notes that the PPI-clopidogrel interaction seems to be less important than once feared, but there are other reasons to be cautious about PPIs. All PPI prescriptions should be reviewed periodically by a doctor to be sure the drug is still needed to treat symptoms. And PPI prescriptions should always be for the lowest dose that’s effective.

Read the full-length article: "Proton-pump inhibitors"

Also in this issue of the Harvard Health Letter

  • Four sob stories
  • The 2010 Dietary Guidelines
  • Proton-pump inhibitors
  • Accountable care organizations
  • In Brief: Routine screening of the carotid arteries not recommended
  • Ask the doctor: Creatine for muscle strength
  • Ask the doctor: Preventing and curing sarcoidosis

More Harvard Health News »

About Harvard Health Publications

Harvard Health Publications publishes four monthly newsletters--Harvard Health Letter, Harvard Women's Health Watch, Harvard Men's Health Watch, and Harvard Heart Letter--as well as more than 50 special health reports and books drawing on the expertise of the 8,000 faculty physicians at Harvard Medical School and its world-famous affiliated hospitals.